Association between anthropometric markers of adiposity, adipokines and vitamin D levels.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 09 2022
Historique:
received: 25 03 2022
accepted: 29 08 2022
entrez: 14 9 2022
pubmed: 15 9 2022
medline: 17 9 2022
Statut: epublish

Résumé

Inverse association between serum levels of vitamin D and obesity has been pointed out in several studies. Our aim was to identify to the associations between vitamin D levels and a large panel of anthropometric markers and adipokines. Cross-sectional study including 6485 participants. Anthropometric markers included body mass index (BMI), % body fat, waist, waist-to-hip (WHR), waist-to-height (WHtR), conicity index, body roundness index (BRI) and a body shape index (ABSI). 55.7% of women and 60.1% of men presented with vitamin D deficiency. Vitamin D levels were negatively associated with most anthropometric markers, with correlation coefficients ranging between -0.017 (ABSI) and -0.192 (BMI) in women and between -0.026 (weight) and -0.130 (% body fat) in men. Vitamin D levels were inversely associated with leptin levels in both sexes and positively associated with adiponectin levels in women only. The likelihood of vitamin D deficiency increased with increasing adiposity levels, except for ABSI (women) and BMI (men). Total body fat, rather than localized or unevenly distributed body fat, is the adiposity marker most associated with decreased vitamin D levels. Monitoring vitamin D levels in people with overweight/obesity is essential.

Identifiants

pubmed: 36104384
doi: 10.1038/s41598-022-19409-9
pii: 10.1038/s41598-022-19409-9
pmc: PMC9474508
doi:

Substances chimiques

Adipokines 0
Biomarkers 0
Vitamins 0
Vitamin D 1406-16-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15435

Informations de copyright

© 2022. The Author(s).

Références

Int J Obes (Lond). 2020 Feb;44(2):280-288
pubmed: 30926948
Curr Opin Clin Nutr Metab Care. 2016 Nov;19(6):464-470
pubmed: 27537278
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
pubmed: 21646368
Rev Endocr Metab Disord. 2017 Jun;18(2):215-225
pubmed: 28229265
Arch Osteoporos. 2020 Apr 2;15(1):55
pubmed: 32240376
Rev Endocr Metab Disord. 2017 Jun;18(2):153-165
pubmed: 28516265
Endocr Metab Immune Disord Drug Targets. 2019;19(6):838-844
pubmed: 30666920
PLoS One. 2020 Dec 28;15(12):e0243850
pubmed: 33370344
J Steroid Biochem Mol Biol. 2017 Jan;165(Pt B):369-381
pubmed: 27520301
Nutrients. 2017 Mar 29;9(4):
pubmed: 28353634
Rapid Commun Mass Spectrom. 2013 Jan 15;27(1):200-6
pubmed: 23239334
Eat Weight Disord. 2020 Dec;25(6):1651-1661
pubmed: 31728924
Swiss Med Wkly. 2012 Nov 26;142:0
pubmed: 23188555
BMC Med. 2014 Nov 07;12:207
pubmed: 25377944
Arq Bras Cardiol. 2005 Jul;85(1):26-31
pubmed: 16041451
Nutrients. 2021 Sep 23;13(10):
pubmed: 34684322
J Clin Endocrinol Metab. 2013 Dec;98(12):4845-51
pubmed: 24037880
Nutr Res Pract. 2020 Dec;14(6):553-567
pubmed: 33282119
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
Bone. 2015 Feb;71:1-6
pubmed: 25284157
J Clin Epidemiol. 1991;44(9):955-6
pubmed: 1890438
Eur J Clin Nutr. 2018 Oct;72(10):1345-1357
pubmed: 29563638
Public Health Nutr. 2020 May;23(7):1214-1222
pubmed: 31120008
PLoS One. 2018 Aug 28;13(8):e0198650
pubmed: 30153256
Eur J Clin Nutr. 2011 Aug;65(8):978-83
pubmed: 21559037
Endocrine. 2017 Jun;56(3):658-666
pubmed: 28417313
Nutrients. 2019 Dec 12;11(12):
pubmed: 31842281
Int J Obes Suppl. 2019 Apr;9(1):20-31
pubmed: 31391922
Obes Rev. 2021 Feb;22(2):e13134
pubmed: 32881271
Obesity (Silver Spring). 2013 Nov;21(11):2264-71
pubmed: 23519954
Clin Interv Aging. 2013;8:1347-51
pubmed: 24124357
Rev Paul Pediatr. 2015 Apr-Jun;33(2):222-9
pubmed: 25890445
Obes Rev. 2012 Mar;13(3):275-86
pubmed: 22106927
Obesity (Silver Spring). 2021 Mar;29(3):562-568
pubmed: 33624437
PLoS One. 2012;7(7):e39504
pubmed: 22815707
Clin Nutr. 2019 Dec;38(6):2851-2857
pubmed: 30635144
Am J Hum Biol. 1996;8(4):489-496
pubmed: 28557078
BMC Cardiovasc Disord. 2008 Mar 17;8:6
pubmed: 18366642

Auteurs

Pollyanna Patriota (P)

Swiss Nutrition and Health Foundation, 1066, Epalinges, Switzerland.

Serge Rezzi (S)

Swiss Nutrition and Health Foundation, 1066, Epalinges, Switzerland.

Idris Guessous (I)

Division of Primary Care Medicine, Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.

Pedro Marques-Vidal (P)

Department of Medicine, Internal Medicine, Lausanne University Hospital, University of Lausanne, Office BH10-642, 46 Rue du Bugnon 46, 1011, Lausanne, Switzerland. Pedro-Manuel.Marques-Vidal@chuv.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH